CME Q3 2025 Earnings
Reported Oct 22, 2025 at 7:05 AM ET · SEC Source
Q3 25 EPS
$2.68
BEAT +1.98%
Est. $2.63
Q3 25 Revenue
$1.54B
BEAT +0.50%
Est. $1.53B
vs S&P Since Q3 25
-17.1%
TRAILING MARKET
CME -7.2% vs S&P +9.9%
Market Reaction
Did CME Beat Earnings? Q3 2025 Results
CME Group posted a modest earnings beat in the third quarter of 2025, with adjusted diluted EPS of $2.68 topping the $2.64 consensus estimate by 1.52%, even as total revenue slipped 3.0% year-over-year to $1.54 billion. The primary drag was a decline… Read more CME Group posted a modest earnings beat in the third quarter of 2025, with adjusted diluted EPS of $2.68 topping the $2.64 consensus estimate by 1.52%, even as total revenue slipped 3.0% year-over-year to $1.54 billion. The primary drag was a decline in clearing and transaction fees, which fell to $1.23 billion from $1.30 billion a year earlier, reflecting a drop in average daily volume to 25,322 thousand contracts from 28,289 thousand in Q3 2024, with interest rate and equity index products leading the pullback. A higher average rate per contract, rising to $0.70 from $0.67, helped cushion the blow, as did record market data revenue of $202.50 million. Looking ahead, CME is leaning into new growth vectors to rebuild momentum; a partnership with FanDuel and the launch of 24/7 cryptocurrency futures and options trading are central to that push, and early signs are encouraging, with October already delivering record average daily volumes driven by a surge in metals and cryptocurrency contracts.
Key Takeaways
- • Second-highest third-quarter ADV driven by global client demand across all asset classes
- • Record market data revenue of $203 million
- • Average rate per contract increased to $0.702 from $0.666 year-over-year
- • Ongoing global uncertainty driving risk management activity
CME YoY Financials
Q3 2025 vs Q3 2024, source: SEC Filings
CME Revenue by Segment
With YoY comparisons, source: SEC Filings
“Global clients continued relying on CME Group markets across all asset classes as they sought to navigate risk and pursue opportunities amid ongoing uncertainty in Q3.”
— Terry Duffy, Q3 2025 Earnings Press Release
CME Earnings Trends
CME vs Market 30 Day Price Reactions
30-day stock return vs benchmark after each earnings
CME EPS Trend
Earnings per share: estimate vs actual
CME Revenue Trend
Quarterly revenue: estimate vs actual
CME Quarterly Results
4 quarters of earnings data
| Quarter | EPS Est. | EPS Act. | Surprise | Revenue | Rev. Surprise |
|---|---|---|---|---|---|
| Q1 26 MISS | $3.38 | $3.36 | -0.55% | $1.88B | -1.50% |
| Q4 25 BEAT FY | $2.74 | $2.77 | +1.00% | $1.65B | +0.29% |
| FY Full Year | — | $11.20 | — | $6.52B | — |
| Q3 25 BEAT | $2.63 | $2.68 | +1.98% | $1.54B | +0.50% |
| Q2 25 BEAT | $2.92 | $2.96 | +1.45% | $1.69B | +0.55% |